Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The P2X7 purinoceptor is a ligand-gated ion channel activated by extracellular ATP. It forms a homo-trimeric complex and is characterized by a long C-terminal tail. Activation leads to cation influx, K+ efflux, and pore formation. It plays a crucial role in inflammation by activating the NLRP3 inflammasome and releasing pro-inflammatory cytokines. It's implicated in various diseases, including cardiovascular and neurodegenerative disorders.
Ligand-gated ion channel activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P2X Purinoceptor 7 Receptor (P2X7).